We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Leica Microsystems' US Acquisition Expands Histopathology Range

By HospiMedica staff writers
Posted on 19 May 2008
In a move that further advances its strong global position in the histopathology field, Leica Microsystems announced the acquisition of the assets of US-based Coretech Holdings. More...
The acquired concern is to become a business unit within Leica Microsystems' Biosystems Division, and will be renamed Leica Biosystems St. Louis, LLC. Terms of the transaction were not disclosed.

Composed of a group of strong brands including McCormick Scientific, The Vibratome Company, Paraplast embedding media, TurbOflow II histology cassettes and myNeuroLab.com, Coretech (St. Louis, MO, USA) provides an extensive range of systems, instruments, reagents, and consumables for the clinical and research histology laboratory.

According to Doug Martin, formerly CEO of Coretech Holdings and now Vice President & General Manager of Leica Biosystems St. Louis, LLC, The synergies created by combining the Coretech products and team with those of Leica Microsystems are considerable. Both companies will quickly leverage an improved product offering for our customers and expand our ability to service their needs.

Anne De Greef-Safft, President of Leica Microsystems' Biosystems Division added, With this acquisition, Leica Microsystems continues to broaden and strengthen the product line we offer our customers. The benefit to customers is that they now have a single partner to come to for all their histology equipment, reagent, and consumable needs. Having internal R&D, as well as manufacturing capabilities for the instrument and their associated reagents and consumables allows us to better optimize the entire system, leading to higher quality and more consistent results for our customers.

Leica Microsystems (Wetzlar, Germany) is a leading global developer and producer of precision optical systems for the analysis of microstructures. The company manufactures a broad range of products requiring microscopic imaging, measurement, and analysis, and offers system solutions for life sciences including biotechnology and medicine, R&D of raw materials, and industrial quality assurance. Leica Microsystems is represented in over 100 countries with 9 manufacturing facilities in 7 countries, sales and service organizations in 19 countries and an international network of dealers.


Related Links:
Coretech
Leica Microsystems

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Xenon Light Source
CLV-S400
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.